FDA Inspection
CSL Behring L.L.C.CSL Behring L.L.C. – FDA Inspection, Jun 25, 2026
Record Details
This FDA Inspection record concerns CSL Behring L.L.C., with an inspection on June 25, 2026, issued by the Chicago District Office, covering biologics.
View Company Profile
ID · 9fcc678f-758f-4327-b47e-b32bb94df0e7
Inspection Facts
- Inspection number
- 1284730
- FDA center
- Biologics
Other FDA inspections of CSL Behring L.L.C.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| March 2, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 23, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 18, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 19, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Behring L.L.C.
- FDA Inspection 1202268 - 2023-03-02
- FDA Inspection 1153026 - 2021-09-24
- FDA Inspection 1090775 - 2019-05-23
- FDA Inspection 1072948 - 2018-10-18
- FDA Inspection 1019044 - 2017-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.